Actinomycetota: the phylum that guards infant guts and causes TB

Picture a family reunion where one cousin spent the last century helping newborns digest their mother's milk, another produced most of the antibiotics in your pharmacy, and a third causes the infection that killed an estimated 1.25 million people in 2023 ¹⁰. That is Actinomycetota. Before you decide whether this phylum is friend or foe, it helps to know what a phylum actually is — and why the answer is "both, depending on which cousin."

What it is

Actinomycetota is a phylum — one of the broadest branches on the bacterial tree — of Gram-positive bacteria whose DNA is unusually rich in the bases guanine and cytosine, which is why microbiologists call them "high-GC." The reference review by Barka and colleagues in Microbiology and Molecular Biology Reviews describes them as one of the largest bacterial phyla, found in soil and water everywhere, with many members growing as branching threads that look, under the microscope, more like a mould than a microbe ². That fungus-like habit is where the name comes from: actino for ray, mykes for fungus.

The phylum's membership is what makes it interesting. Barka's review lists gut commensals (Bifidobacterium), soil dwellers (Streptomyces, Micromonospora), plant partners (Frankia), and pathogens — Corynebacterium, Mycobacterium, Nocardia, Propionibacterium, Tropheryma — all under one roof ².

Two names, one phylum

Until recently the group was called Actinobacteria, and you will still see that word in most papers, most sequencing reports and most probiotic labels. In 2021 the International Committee on Systematics of Prokaryotes added the rank of phylum to the official naming code, and Oren and Garrity published formal names for 42 phyla, each anchored to a type genus ¹. This one was anchored to Actinomyces, hence Actinomycetota. The NCBI Taxonomy database lists the phylum under that name, with Actinobacteria and Actinobacteriota as synonyms. Nothing biological changed. If a study says Actinobacteria, it is talking about exactly this group.

Where it lives in you

Gut. In adults, Actinomycetota is one of the four major phyla of the gut microbiota — and yet, as Binda and colleagues put it in their 2018 review, it "represents only a small percentage" of the community while being "pivotal in the maintenance of gut homeostasis" ³. Small in headcount, large in effect. The genus that carries that effect is Bifidobacterium.

In infants the picture flips. The breast-fed newborn gut is often dominated by bifidobacteria, and the genome of Bifidobacterium longum subsp. infantis, sequenced by Sela and colleagues in 2008, shows why: a 43 kbp cluster of catabolic genes, solute-binding proteins and permeases predicted to act on milk oligosaccharides — sugars in breast milk that have no nutritive value to the newborn itself ⁴. Mother makes a food her child cannot use, for a bacterium that can. That is not an accident of evolution; it is a recruitment strategy.

Mouth. The Human Oral Microbiome Database built by Dewhirst and colleagues catalogues 619 oral taxa across 13 phyla, Actinobacteria among them ⁸. Its oral members include Actinomyces, which, as Valour and colleagues note, "normally colonize the human mouth and digestive and genital tracts" without causing any trouble ⁹.

Skin. Grice and Segre's review in Nature Reviews Microbiology describes skin colonisation as driven by the ecology of each site — oily, moist or dry — and notes that most residents are harmless or even beneficial ⁶. The phylum's headline skin resident is Cutibacterium acnes, formerly Propionibacterium acnes, which Dréno and colleagues describe as "involved in the maintenance of a healthy skin" ⁷. Hold that thought.

What it does for us

It feeds a defence. The clearest mechanistic evidence comes from Fukuda and colleagues in Nature, 2011 ⁵. Mice colonised with particular bifidobacterial strains survived an otherwise lethal dose of Escherichia coli O157:H7 ⁵. The protection traced to genes for an ATP-binding-cassette carbohydrate transporter and, the authors write, "at least in part" to the increased acetate those strains produced; translocation of the bacterium's Shiga toxin from gut lumen to blood was inhibited ⁵. A short-chain fatty acid, made from sugar by a gut resident, reinforcing the gut wall. Caveat, said out loud: these were mice, and only some strains carried the protective genes. Which strain matters more than which phylum.

It digests what you cannot. The milk-sugar machinery of B. infantis ⁴ is the best-studied case of a bacterium turning an indigestible dietary component into something the host benefits from.

It makes medicine — outside you. About two-thirds of the naturally derived antibiotics in current clinical use come from this phylum, mostly from soil Streptomyces, along with many anticancer, anthelmintic and antifungal compounds ². Worth being honest here: the drug producers are not the bacteria living in your gut. Same family, different neighbourhood.

It may work as a probiotic. Binda's review notes that bifidobacteria are widely used as probiotics and have shown "beneficial effects in many pathological conditions" — and then adds, in the same sentence, that "larger in vivo studies are needed to confirm such encouraging results" ³. That caveat is the state of the evidence, and it belongs in any honest sentence about the topic.

What it does against us

Tuberculosis. Mycobacterium tuberculosis is a member of this phylum. The Korea Disease Control and Prevention Agency's summary of the WHO Global Tuberculosis Report 2024 puts the numbers plainly: an estimated 10.8 million people fell ill with TB in 2023 and 1.25 million died; about a quarter of the world's population is estimated to carry the infection; treatment takes a minimum of 6 months ¹⁰. The phylum's best-known member is also its deadliest.

Diphtheria, nocardiosis, Whipple's disease. The pathogen list in Barka's review — Corynebacterium, Nocardia, Tropheryma — reads like a chapter of an infectious-disease textbook ².

Acne — but not the way you think. Here is the contrarian part. Dréno and colleagues report that "proliferation of P. acnes is not the trigger of acne as patients with acne do not harbour more P. acnes in follicles than normal individuals." Instead, a loss of skin microbial diversity together with innate immune activation appears to drive the condition ⁷. The bacterium is a resident on everybody; the disease is an imbalance, not an invasion.

Actinomycosis. The same Actinomyces that sit quietly in your mouth can, rarely, cause a chronic abscess-forming infection — typically in the face and neck after a dental focus, or in the lungs of smokers with poor dental hygiene. Valour's review describes 6 to 12 months of high-dose penicillin as the standard course and names better dental hygiene as a preventive measure ⁹. Commensal by default, pathogen by opportunity.

The caveat that covers all of it

A phylum is a coarse category. The Human Microbiome Project found that even healthy people "differ remarkably" in the microbes occupying their gut, skin and other habitats ¹¹. A stool report that says "Actinobacteria: low" or "high" is blending bifidobacteria, Actinomyces and everything in between into one number, and there is no evidence that pushing that number in either direction is a health goal. The evidence that exists lives at the level of species and strain — a particular Bifidobacterium carrying a particular gene cluster, a specific set of genes, in a particular host, a particular person. That is where any honest claim has to start.